Liquidia Technologies Inc.

The momentum for this stock is not very good. Liquidia Technologies Inc. is not a good value stock. Liquidia Technologies Inc. is not a good growth stock. Liquidia Technologies Inc. is not very popular among insiders. Liquidia Technologies Inc. is a mediocre stock to choose.
Log in to see more information.
Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and c...
LQDA Fundamental Data by TradingView

News

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?
Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?

Zacks Investment Research Liquidia Technologies, Inc. (LQDA) shares rallied 14.1% in the last trading session to close at $10.16. This move can be attributable to notable volume with a higher number of shares being traded...\n more…

North Carolina drug company secures $100M at pivotal juncture
North Carolina drug company secures $100M at pivotal juncture

BizJournals.com - Nat'l Business News Liquidia is extending its cash runway as it battles the FDA over the status of its lead drug.\n more…

Liquidia stock rises after it prices public and private offering
Liquidia stock rises after it prices public and private offering

Seeking Alpha - Healthcare Liquidia stock rises after it prices public and private offering...\n more…

Liquidia announces raise of $67.5M from common stock financings
Liquidia announces raise of $67.5M from common stock financings

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement

Globe Newswire MORRISVILLE, N.C., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (the Company or Liquidia ), a biopharmaceutical company developing innovative therapies for patients...\n more…

Liquidia Co. (NASDAQ:LQDA) Receives $23.14 Average PT from Brokerages
Liquidia Co. (NASDAQ:LQDA) Receives $23.14 Average PT from Brokerages

Ticker Report Liquidia Co. (NASDAQ:LQDA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight brokerages that are presently covering the firm, Marketbeat reports. One...\n more…